First Case of Cytokine Release Syndrome after Nivolumab for Gastric Cancer
Conclusion: To the best of our knowledge, this is the first report of nivolumab-induced CRS in a patient with gastric cancer.Case Rep Oncol 2019;12:147 –156
Source: Case Reports in Oncology - Category: Cancer & Oncology Source Type: research
More News: Allergy | Allergy & Immunology | Autoimmune Disease | Bile | Cancer | Cancer & Oncology | Chemotherapy | CT Scan | Gastric (Stomach) Cancer | Gastroenterology | Liver | Urology & Nephrology